ABVC BioPharma (ABVC)

• Market cap: $70.6M
• 1 day: 2.74%
• 5 days: 3.09%
• 1 month: 4.53%
• 3 months: -14.77%
• 6 months: 243.68%
• Year to date: 367.8%
• 1 year: 455.56%
• 5 years: -89.97%
• 10 years: -89.97%
• Sector: Healthcare
• Industry: Biotechnology

About: ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Employees: 19